Downsizing genomic medicine: Approaching the ethical complexity of whole-genome sequencing by starting small

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

As we look to a time when whole-genome sequencing is integrated into patient care, it is possible to anticipate a number of ethical challenges that will need to be addressed. The most intractable of these concern informed consent and the responsible management of very large amounts of genetic information. Given the range of possible findings, it remains unclear to what extent it will be possible to obtain meaningful patient consent to genomic testing. Equally unclear is how clinicians will disseminate the enormous volume of genetic information produced by whole-genome sequencing. Toward developing practical strategies for managing these ethical challenges, we propose a research agenda that approaches multiplexed forms of clinical genetic testing as natural laboratories in which to develop best practices for managing the ethical complexities of genomic medicine.

Original languageEnglish (US)
Pages (from-to)191-194
Number of pages4
JournalGenetics in Medicine
Volume13
Issue number3
DOIs
StatePublished - Mar 2011
Externally publishedYes

Fingerprint

Medicine
Genome
Genetic Testing
Informed Consent
Practice Guidelines
Patient Care
Research

Keywords

  • ethical
  • informed consent
  • legal and social issues
  • personalized medicine
  • return of results
  • whole genome sequencing

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Downsizing genomic medicine : Approaching the ethical complexity of whole-genome sequencing by starting small. / Sharp, Richard R.

In: Genetics in Medicine, Vol. 13, No. 3, 03.2011, p. 191-194.

Research output: Contribution to journalArticle

@article{e0d5726eac7840d89e43a09f5cd2ee02,
title = "Downsizing genomic medicine: Approaching the ethical complexity of whole-genome sequencing by starting small",
abstract = "As we look to a time when whole-genome sequencing is integrated into patient care, it is possible to anticipate a number of ethical challenges that will need to be addressed. The most intractable of these concern informed consent and the responsible management of very large amounts of genetic information. Given the range of possible findings, it remains unclear to what extent it will be possible to obtain meaningful patient consent to genomic testing. Equally unclear is how clinicians will disseminate the enormous volume of genetic information produced by whole-genome sequencing. Toward developing practical strategies for managing these ethical challenges, we propose a research agenda that approaches multiplexed forms of clinical genetic testing as natural laboratories in which to develop best practices for managing the ethical complexities of genomic medicine.",
keywords = "ethical, informed consent, legal and social issues, personalized medicine, return of results, whole genome sequencing",
author = "Sharp, {Richard R}",
year = "2011",
month = "3",
doi = "10.1097/GIM.0b013e31820f603f",
language = "English (US)",
volume = "13",
pages = "191--194",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Downsizing genomic medicine

T2 - Approaching the ethical complexity of whole-genome sequencing by starting small

AU - Sharp, Richard R

PY - 2011/3

Y1 - 2011/3

N2 - As we look to a time when whole-genome sequencing is integrated into patient care, it is possible to anticipate a number of ethical challenges that will need to be addressed. The most intractable of these concern informed consent and the responsible management of very large amounts of genetic information. Given the range of possible findings, it remains unclear to what extent it will be possible to obtain meaningful patient consent to genomic testing. Equally unclear is how clinicians will disseminate the enormous volume of genetic information produced by whole-genome sequencing. Toward developing practical strategies for managing these ethical challenges, we propose a research agenda that approaches multiplexed forms of clinical genetic testing as natural laboratories in which to develop best practices for managing the ethical complexities of genomic medicine.

AB - As we look to a time when whole-genome sequencing is integrated into patient care, it is possible to anticipate a number of ethical challenges that will need to be addressed. The most intractable of these concern informed consent and the responsible management of very large amounts of genetic information. Given the range of possible findings, it remains unclear to what extent it will be possible to obtain meaningful patient consent to genomic testing. Equally unclear is how clinicians will disseminate the enormous volume of genetic information produced by whole-genome sequencing. Toward developing practical strategies for managing these ethical challenges, we propose a research agenda that approaches multiplexed forms of clinical genetic testing as natural laboratories in which to develop best practices for managing the ethical complexities of genomic medicine.

KW - ethical

KW - informed consent

KW - legal and social issues

KW - personalized medicine

KW - return of results

KW - whole genome sequencing

UR - http://www.scopus.com/inward/record.url?scp=79952185587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952185587&partnerID=8YFLogxK

U2 - 10.1097/GIM.0b013e31820f603f

DO - 10.1097/GIM.0b013e31820f603f

M3 - Article

C2 - 21311340

AN - SCOPUS:79952185587

VL - 13

SP - 191

EP - 194

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 3

ER -